Single-chain variable fragment of Met monoclonal antibody and methods of use in CAR T… Grant US-11866493-B2 United States of America 09 Jan 2024
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11851491-B2 United States of America 26 Dec 2023
Chimeric antigen and T cell receptors and methods of use Grant US-11793834-B2 United States of America 24 Oct 2023
Method of reducing mesothelin-expressing tumor burden by administration of T cells… Grant US-11702472-B2 United States of America 18 Jul 2023
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application EP-4166148-A1 European Patent Office 19 Apr 2023
Bispecific T cell engaging antibody constructs Grant US-11434302-B2 United States of America 06 Sep 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11377638-B2 United States of America 05 Jul 2022
Chimeric antigen receptor anti-inflammatory cells and methods of use Grant US-11365391-B2 United States of America 21 Jun 2022
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11242376-B2 United States of America 08 Feb 2022
Immune cell compositions and methods of use Grant US-11242375-B2 United States of America 08 Feb 2022
Method for treating glioblastoma or glioma with antibody constructs for EGFRVIII and CD3 Grant US-11155629-B2 United States of America 26 Oct 2021
PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PANCREATIC CANCER Grant NL-2024515-B1 Netherlands 02 Sep 2021
OCTS technology-based pancreatic cancer and malignant mesothelioma CAR-T therapeutic… Grant US-11098123-B2 United States of America 24 Aug 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11085021-B2 United States of America 10 Aug 2021
TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY Grant EP-3194443-B1 European Patent Office 14 Jul 2021
Compositions and methods for TCR reprogramming using fusion proteins Grant US-11028142-B2 United States of America 08 Jun 2021
SINGLE-CHAIN VARIABLE FRAGMENT OF MET MONOCLONAL ANTIBODY AND METHODS OF USE IN CAR T… Application US-20210130456-A1 United States of America 06 May 2021
TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY Application US-20200377589-A1 United States of America 03 Dec 2020
Treatment of cancer using a CD33 chimeric antigen receptor Grant US-10851166-B2 United States of America 01 Dec 2020
Conjugates of IL13Rα2 binding agents and use thereof in cancer treatment Grant US-10851169-B2 United States of America 01 Dec 2020
Method of redirecting T cells to treat HIV infection Grant US-10738099-B2 United States of America 11 Aug 2020
PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PANCREATIC CANCER Application WO-2020159361-A1 World Intellectual Property Organisation (WIPO) 06 Aug 2020
PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF PANCREATIC CANCER Application WO-2020159360-A1 World Intellectual Property Organisation (WIPO) 06 Aug 2020
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application EP-3685842-A1 European Patent Office 29 Jul 2020
SELF REPLICATING RNA SYSTEM Application WO-2020092387-A1 World Intellectual Property Organisation (WIPO) 07 May 2020
Chimeric antigen receptors, compositions, and methods Grant US-10640570-B2 United States of America 05 May 2020
Mesothelin-targeted chimeric antigen receptors and uses thereof Grant US-10633441-B2 United States of America 28 Apr 2020
Mesothelin-targeted chimeric antigen receptors and methods of making them Grant US-10538588-B2 United States of America 21 Jan 2020
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10442849-B2 United States of America 15 Oct 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358474-B2 United States of America 23 Jul 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10358473-B2 United States of America 23 Jul 2019
IL13Rα2 binding agents and use thereof in cancer treatment Grant US-10308719-B2 United States of America 04 Jun 2019
RNA REPLICON FOR EXPRESSING A T CELL RECEPTOR OR AN ARTIFICIAL T CELL RECEPTOR Application WO-2019053056-A1 World Intellectual Property Organisation (WIPO) 21 Mar 2019
Bispecific binding proteins that bind CD40 and mesothelin Grant US-10233258-B2 United States of America 19 Mar 2019
Compositions and methods for TCR reprogramming using fusion proteins Grant US-10208285-B2 United States of America 19 Feb 2019
OCTS TECHNOLOGY-BASED PANCREATIC CANCER AND MALIGNANT MESOTHELIOMA CAR-T THERAPEUTIC… Application WO-2018218879-A1 World Intellectual Property Organisation (WIPO) 06 Dec 2018
Treatment of cancer using a CD33 chimeric antigen receptor Grant US-9777061-B2 United States of America 03 Oct 2017
TARGETING CYTOTOXIC CELLS WITH CHIMERIC RECEPTORS FOR ADOPTIVE IMMUNOTHERAPY Application EP-3194443-A1 European Patent Office 26 Jul 2017
MESOTHELIN-TARGETED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application WO-2015188141-A2 World Intellectual Property Organisation (WIPO) 10 Dec 2015